EpiWatch, Inc.
Baltimore, MD, United States · Healthcare, Health Care · 9 employees
EpiWatch will transform neurology care by offering FDA-cleared healthcare solutions and comprehensive care management through an accessible and convenient AI-powered smartwatch/smartphone platform that will reduce cost and improve access, outcomes, and safety.
Funding history
- Series pre-seed — $190K — Oct 2024
- Funding Round — $250K — Jul 2024
- Series seed — $300K — Jan 2024
- Series seed — $340K — Jun 2023
- Funding Round — $250K — Sep 2022
Recent signals
- Oct 22, 2024: Raised $190K in Series pre-seed
- Jul 11, 2024: Raised $250K
- Apr 16, 2024: EpiWatch Inc. Appoints Teresa Prego as Chief Executive Officer, Dean Papadopoulos as Chief Strategist
- Jan 22, 2024: Raised $300K in Series seed
- Jun 06, 2023: Raised $340K in Series seed
- Sep 12, 2022: Raised $250K
- Mar 07, 2022: Raised $415K in Series seed
- May 13, 2021: Raised $450K in Series seed
See plans & pricing → Track EpiWatch, Inc.’s funding, hiring, and signals — with verified contacts — on Fundz.